Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin–proteasome pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin–proteasome pathway

Published:2014-11 Issue:11 Volume:5 Page:e1513-e1513
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Ohoka N,Nagai K,Hattori T,Okuhira K,Shibata N,Cho N,Naito M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2014471.pdf

Reference44 articles.

1. Sudakin V, Yen TJ . Targeting mitosis for anti-cancer therapy. BioDrugs 2007; 21: 225–233.

2. Lens SM, Voest EE, Medema RH . Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 2010; 10: 825–841.

3. Jackson JR, Patrick DR, Dar MM, Huang PS . Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer 2007; 7: 107–117.

4. Hood FE, Royle SJ . Pulling it together: the mitotic function of TACC3. Bioarchitecture 2011; 1: 105–109.

5. Gergely F, Karlsson C, Still I, Cowell J, Kilmartin J, Raff JW . The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. Proc Natl Acad Sci USA 2000; 97: 14352–14357.

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment;International Journal of Biological Macromolecules;2024-08

2. Detection of small molecule compounds bound to proteins;Chinese Journal of Analytical Chemistry;2024-06

3. Structural Considerations and Chemistry of PROTACs;PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics;2024

4. PROTACs in the Management of Prostate Cancer;PROTAC-Mediated Protein Degradation: A Paradigm Shift in Cancer Therapeutics;2024

5. TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness;Cell Cycle;2023-12-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3